We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
-14.02%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.8B
AUM Growth
-$5.38B
(-15%)
Cap. Flow
-$124M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
1,405
New
73
Increased
464
Reduced
559
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$350M |
| 2 |
Amazon
AMZN
|
+$74.8M |
| 3 |
DuPont de Nemours
DD
|
+$68.9M |
| 4 |
Integra LifeSciences
IART
|
+$55.5M |
| 5 |
Electronic Arts
EA
|
+$51.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$408M |
| 2 |
A.O. Smith
AOS
|
+$198M |
| 3 |
Bankunited
BKU
|
+$60.1M |
| 4 |
Adobe
ADBE
|
+$52.7M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$48.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.8% |
| 2 | Healthcare | 16.59% |
| 3 | Financials | 15.49% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
251
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $16.8M | 0.06% |
+453,409
| New | +$16.3M |
|
252
Barings BDC
BBDC
$868M
| $16.7M | 0.06% |
1,853,146
-157,759
| -8% | -$1.56M |
|
253
Vanguard Extended Market ETF
VXF
$30.5B
| $16.7M | 0.06% |
167,240
-22,152
| -12% | -$2.43M |
|
254
Ross Stores
ROST
$78.1B
| $16.6M | 0.06% |
199,028
+41,547
| +26% | +$3.76M |
|
255
Triumph Financial Inc
TFIN
$1.8B
| $16.6M | 0.06% |
557,444
+63,756
| +13% | +$2.25M |
|
256
Clarus
CLAR
$126M
| $16.5M | 0.06% |
1,636,100
+11,340
| +0.7% | +$119K |
|
|
DESP
257
DELISTED
Despegar.com
DESP
| $16.4M | 0.06% |
1,324,520
+847,663
| +178% | +$12.8M |
|
|
ROAN
258
DELISTED
Roan Resources, Inc.
ROAN
| $16.4M | 0.06% |
+1,953,155
| New | +$21.1M |
|
259
Microchip Technology
MCHP
$42.3B
| $16.4M | 0.05% |
454,700
-67,470
| -13% | -$2.38M |
|
|
JBGS
260
JBG SMITH
JBGS
$832M
| $16.3M | 0.05% |
467,053
-9,791
| -2% | -$368K |
|
261
Blackstone
BX
$106B
| $16.2M | 0.05% |
543,437
-15,035
| -3% | -$497K |
|
262
Enbridge
ENB
$121B
| $16.2M | 0.05% |
520,451
-18,571
| -3% | -$597K |
|
|
WDR
263
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $16.1M | 0.05% |
889,147
+565,881
| +175% | +$11M |
|
264
Agios Pharmaceuticals
AGIO
$2.2B
| $16M | 0.05% |
347,513
+3,736
| +1% | +$231K |
|
265
Medtronic
MDT
$108B
| $16M | 0.05% |
176,114
+5,181
| +3% | +$484K |
|
|
TCF
266
DELISTED
TCF Financial Corporation
TCF
| $16M | 0.05% |
821,596
+810,110
| +7,053% | +$17.5M |
|
267
McCormick & Company Non-Voting
MKC
$13.6B
| $15.9M | 0.05% |
227,688
+23,436
| +11% | +$1.68M |
|
268
Aflac
AFL
$64.4B
| $15.8M | 0.05% |
347,517
+2,985
| +0.9% | +$133K |
|
269
REX American Resources
REX
$1.44B
| $15.7M | 0.05% |
1,379,154
-115,068
| -8% | -$1.35M |
|
270
iShares MSCI ACWI ex US ETF
ACWX
$11.4B
| $15.6M | 0.05% |
371,389
+169,613
| +84% | +$7.48M |
|
271
Church & Dwight Co
CHD
$23.4B
| $15.5M | 0.05% |
235,233
-43,958
| -16% | -$2.78M |
|
272
Dick's Sporting Goods
DKS
$18.4B
| $14.9M | 0.05% |
+477,983
| New | +$16.6M |
|
273
Central Pacific Financial
CPF
$1.01B
| $14.9M | 0.05% |
610,875
-52,661
| -8% | -$1.39M |
|
274
Hain Celestial
HAIN
$46M
| $14.7M | 0.05% |
+923,957
| New | +$20.6M |
|
275
Workday
WDAY
$36.4B
| $14.6M | 0.05% |
91,303
-18,370
| -17% | -$2.6M |
|
Similar funds
QCM
Brown Advisory's Q4 2018 Portfolio in Review
As of Q4 2018, Brown Advisory held 1,405 positions worth $29.8B, down 15% from $35.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Brown Advisory's Q4 2018 filing shows 73 new, 464 increased, 559 reduced and 158 closed positions. Its largest new stake was Integra LifeSciences: 1,012,273 shares worth $45.7M. The largest sale was Meta Platforms (Facebook), an estimated $408M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2018 buy was Integra LifeSciences: 1,012,273 shares worth $45.7M.
- Brown Advisory added most to Microsoft in Q4 2018, an estimated $350M increase.
- Brown Advisory's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $408M.
- Brown Advisory fully exited Forest City Realty Trust, Inc. in Q4 2018, selling an estimated $48.5M.
- Brown Advisory's ten largest holdings make up 21% of its $29.8B portfolio in Q4 2018.
- Brown Advisory opened 73 new positions and closed 158 in Q4 2018.
- Brown Advisory's portfolio value fell 15% quarter-over-quarter to $29.8B.
Based on Brown Advisory's 13F filing for Q4 2018, filed 13 Feb 2019.